AddLife acquires Austrian Biomedica, a parent company in a group with a turnover of approximately EUR 65 million, operating in 13 countries in Europe with 280 employees. Biomedica supplies, like AddLife, products and services in laboratory engineering and medical technology to mainly publicly funded healthcare. Biomedica becomes part of both Medtech and Labtech.
Labtech offers products and services to diagnostics and biomedical research and laboratory analysis.
MORE ABOUT LABTECHMedtech offers medical device products to the publicly funded health care.
MORE ABOUT MEDTECHWe develop your company through active ownership. AddLife acquires companies in order to maintain and further develop them in the long term.
MORE ABOUT AQUISITIONSThe Nordic countries, AddLife’s home market, have a growing and aging population, which increases the need for health care and social services. Constructive collaboration between society, research and business is therefore important to meet the expectations of citizens. AddLife actively contributes with its high-quality laboratory and medical technology.
AddLife´s business concept is to add value to customers within healthcare, laboratories and research. We shall achieve this by offering cost efficient high quality products and solutions combined with qualified advisory services to the private and public sector in the Nordics
MORE ABOUT ADDLIFE
